E. Spreghini, F. Orlando, D. Giannini and F. Barchiesi, “In Vitro and in Vivo Activities of Posaconazole against Zygomycetes with Various Degrees of Susceptibility,” Journal of Antimicrobial Chemotherapy, Vol. 65, No. 10, 2010, pp. 2158-2163. doi:10.1093/jac/dkq276

has been cited by the following article:

• TITLE: Mucormycosis: A Review on Environmental Fungal Spores and Seasonal Variation of Human Disease

  AUTHORS: Rima I. El-Herte, Tania A. Baban, Souha S. Kanj

  KEYWORDS: Mucormycosis; Seasonal Variation; Fungal Air Particulate Concentration; Mucor; Rhizopus; Rhinocerebral

  JOURNAL NAME: Advances in Infectious Diseases, Vol.2 No.3, September 27, 2012

  ABSTRACT: Mucormycosis is on the rise especially among patients with immunosuppressive conditions. There seems to be more cases seen at the end of summer and towards early autumn. Several studies have attempted to look at the seasonal variations of fungal pathogens in variou indoor and outdoor settings. Only two reports, both from the Middle East, have addressed the relationship of mucormycosis in human disease with climate conditions. In this paper we review, the relationship of indoor and outdoor fungal particulates to the weather conditions and the reported seasonal variation of human cases.